Market Closed -
Bombay S.E.
11:00:49 09/05/2024 BST
|
5-day change
|
1st Jan Change
|
306.6
INR
|
-5.66%
|
|
-10.91%
|
-7.98%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,366
|
3,660
|
1,687
|
7,935
|
9,077
|
5,983
|
Enterprise Value (EV)
1 |
2,530
|
3,812
|
1,822
|
8,234
|
9,981
|
6,961
|
P/E ratio
|
19.2
x
|
7.93
x
|
5.36
x
|
24.4
x
|
42.5
x
|
86.3
x
|
Yield
|
0.53%
|
0.34%
|
-
|
0.63%
|
0.27%
|
-
|
Capitalization / Revenue
|
1.33
x
|
1.56
x
|
0.9
x
|
3.96
x
|
2.78
x
|
1.56
x
|
EV / Revenue
|
1.42
x
|
1.63
x
|
0.97
x
|
4.11
x
|
3.06
x
|
1.81
x
|
EV / EBITDA
|
11.1
x
|
7.15
x
|
5.52
x
|
22.3
x
|
24.1
x
|
19
x
|
EV / FCF
|
241
x
|
-30.4
x
|
-16
x
|
-26.5
x
|
-14.6
x
|
-142
x
|
FCF Yield
|
0.41%
|
-3.29%
|
-6.24%
|
-3.78%
|
-6.84%
|
-0.71%
|
Price to Book
|
3.25
x
|
3.16
x
|
1.16
x
|
4.58
x
|
4.69
x
|
3.02
x
|
Nbr of stocks (in thousands)
|
24,940
|
24,940
|
24,940
|
24,940
|
24,940
|
24,940
|
Reference price
2 |
94.85
|
146.8
|
67.65
|
318.2
|
364.0
|
239.9
|
Announcement Date
|
30/08/18
|
23/08/19
|
18/08/20
|
30/08/21
|
22/08/22
|
19/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,782
|
2,341
|
1,877
|
2,001
|
3,263
|
3,847
|
EBITDA
1 |
228.4
|
533.1
|
330.2
|
369.2
|
414.6
|
367.3
|
EBIT
1 |
187.6
|
489.5
|
271.6
|
302.1
|
336.8
|
194.6
|
Operating Margin
|
10.53%
|
20.91%
|
14.47%
|
15.09%
|
10.32%
|
5.06%
|
Earnings before Tax (EBT)
1 |
156.4
|
472.2
|
258.5
|
340.4
|
341.4
|
106
|
Net income
1 |
123
|
461.4
|
314.6
|
325.8
|
213.4
|
69.31
|
Net margin
|
6.9%
|
19.71%
|
16.77%
|
16.28%
|
6.54%
|
1.8%
|
EPS
2 |
4.930
|
18.50
|
12.62
|
13.06
|
8.557
|
2.779
|
Free Cash Flow
1 |
10.49
|
-125.3
|
-113.8
|
-311.2
|
-683
|
-49.11
|
FCF margin
|
0.59%
|
-5.35%
|
-6.06%
|
-15.55%
|
-20.93%
|
-1.28%
|
FCF Conversion (EBITDA)
|
4.59%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
8.53%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.5000
|
0.5000
|
-
|
2.000
|
1.000
|
-
|
Announcement Date
|
30/08/18
|
23/08/19
|
18/08/20
|
30/08/21
|
22/08/22
|
19/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
164
|
152
|
135
|
299
|
904
|
978
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.7182
x
|
0.2853
x
|
0.4081
x
|
0.8098
x
|
2.181
x
|
2.663
x
|
Free Cash Flow
1 |
10.5
|
-125
|
-114
|
-311
|
-683
|
-49.1
|
ROE (net income / shareholders' equity)
|
18.5%
|
48.9%
|
24.1%
|
20.5%
|
11.6%
|
3.54%
|
ROA (Net income/ Total Assets)
|
7.73%
|
17.7%
|
8.48%
|
7.94%
|
6.5%
|
3.1%
|
Assets
1 |
1,591
|
2,602
|
3,709
|
4,103
|
3,281
|
2,236
|
Book Value Per Share
2 |
29.20
|
46.40
|
58.10
|
69.40
|
77.60
|
79.50
|
Cash Flow per Share
2 |
1.520
|
1.530
|
3.330
|
1.570
|
0.9100
|
0.6300
|
Capex
1 |
85
|
138
|
170
|
473
|
987
|
219
|
Capex / Sales
|
4.77%
|
5.89%
|
9.04%
|
23.64%
|
30.26%
|
5.69%
|
Announcement Date
|
30/08/18
|
23/08/19
|
18/08/20
|
30/08/21
|
22/08/22
|
19/08/23
|
|
1st Jan change
|
Capi.
|
---|
| -7.98% | 97.11M | | +6.15% | 105B | | -4.19% | 65.16B | | +51.90% | 42.93B | | +17.59% | 39.48B | | +6.89% | 33.27B | | +12.40% | 19.92B | | +16.25% | 17.49B | | +20.35% | 15.43B | | +9.86% | 15.09B |
Other Commodity Chemicals
|